EAM
IRON icon

Eagle Asset Management’s Disc Medicine IRON Stock Holding History

Eagle Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.41M Sell
83,215
-15,460
-16% -$726K 0.03% 381
2024
Q2 		$4.59M Sell
98,675
-17,063
-15% -$580K 0.02% 404
2024
Q1 		$3.96M Buy
+115,738
New +$7.5M 0.02% 417

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eagle Asset Management's IRON Position: Q3 2024 in Review

Eagle Asset Management reduced its Disc Medicine (IRON) stake by 16% in Q3 2024, selling an estimated $726K and leaving 83,215 shares worth $5.41M. The position accounts for 0.03% of the portfolio, ranked #381.

Eagle Asset Management first reported a position in IRON in Q1 2024 and has held it in 3 quarters since. 132 funds tracked by Wall St. Rank hold IRON as of Q3 2024.

  • Eagle Asset Management held 83,215 shares of Disc Medicine worth $5.41M as of Q3 2024.
  • Eagle Asset Management sold 15,460 Disc Medicine shares in Q3 2024, an estimated $726K.
  • Disc Medicine made up 0.03% of Eagle Asset Management's portfolio in Q3 2024, its #381 holding.
  • Eagle Asset Management first reported a position in Disc Medicine in Q1 2024 and has held it in 3 quarters since.
  • 132 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.